Acer therapeutics to participate in january 2022 virtual investor conferences

Newton, mass., dec. 22, 2021 (globe newswire) -- acer therapeutics inc. (nasdaq: acer), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today announced that acer's management team will participate in the upcoming 11th annual lifesci partners corporate access virtual event and the h.c. wainwright bioconnect virtual conference.
ACER Ratings Summary
ACER Quant Ranking